NASDAQ:GDS

GDS Holdings Limited (NASDAQ:GDS) Sees Positive Analyst Sentiment Amid Growth Prospects

Font: Financial Modeling Prep  • Nov 18, 2025

Market Chart
  • Analysts have set an average price target of $46.7 for GDS, indicating a positive outlook and a potential upside of 25.2%.
  • The price target has increased from $40.44 a year ago, reflecting growing optimism about GDS's future potential in the data center industry.
  • Despite a recent 8.1% surge in share price, earnings estimate revisions suggest caution, yet overall sentiment remains optimistic.

GDS Holdings Limited (NASDAQ:GDS) is a key player in China's data center industry, providing services like colocation, managed hosting, and cloud services. Analysts have been closely monitoring GDS's stock, with the consensus price target showing a positive trend over time. This reflects growing confidence in GDS's strategic position and potential in the expanding data center market.

Last month, analysts set an average price target of $46.7 for GDS, indicating a positive outlook. This sentiment remained steady over the last quarter, suggesting continued confidence in GDS's performance and growth prospects. The consistency in the price target highlights analysts' belief in the company's ability to maintain its market position.

A year ago, the average price target for GDS was $40.44, showing a significant increase over the year. This upward trend suggests growing optimism among analysts about GDS's future potential. As highlighted by Credit Suisse, analyst Clive Cheung has set a price target of $48.9, further indicating a positive outlook for the company's stock.

Despite a recent 8.1% surge in GDS's share price, the current trend in earnings estimate revisions does not suggest sustained strength in the near future. However, Wall Street analysts have set an average price target suggesting a potential upside of 25.2%. This indicates that while there may be some skepticism, the overall sentiment remains optimistic.

GDS recently held its Q2 2025 earnings conference call, attended by key company figures and analysts from major financial institutions. The call discussed GDS's financial performance and strategic initiatives, reinforcing the positive sentiment among analysts. This ongoing dialogue with analysts and investors is crucial for maintaining confidence in GDS's growth trajectory.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.25
30.99%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.69
-2.89%
SBFM
Sunshine Biopharma, Inc.
$0.52
40.59%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.29
-2.93%
NVDA
NVIDIA Corporation
$219.51
-1.77%
RGTI
Rigetti Computing, Inc.
$22.04
30.57%
BITO
ProShares - Bitcoin ETF
$10.60
0.00%
WOK
WORK Medical Technology Group Ltd.
$0.16
-17.99%
NCPL
Netcapital Inc.
$0.81
77.40%
CXAI
CXApp Inc.
$0.20
12.36%